Clinical Trial Update: Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on pifenidone for prophylaxis of radiation-induced lung injury in patients who previously received immune checkpoint inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• pifenidone (pifenidone)

Snippet

Sponsor: Hubei Cancer Hospital | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN